Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Category Archives: Smoking cessation
Rapid Update 1-September 2018: Smoking cessation: Weight gain after quitting smoking temporarily increases risk of type 2 diabetes but is far outweighed by reductions in CV and all-cause mortality
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Smoking cessation: large randomised controlled trial finds varenicline and bupropion do not increase the risk of neuropsychiatric adverse events (Jul-16)
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Type 1 and 2 diabetes: new meta-analysis quantifies risks of smoking (Dec-15)
Authorised users need to be logged in to read this content.
Smoking cessation: some new reassuring evidence that varenicline is not associated with an increased risk of suicide or depression (May-15)
Authorised users need to be logged in to read this content.
NPC Archive Item: New safety information for pioglitazone▼, dronedarone▼, varenicline▼, and Pandemrix®▼
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25 July 2011 The European Medicines Agency (EMA) has issued/updated safety information regarding pioglitazone▼, dronedarone▼, varenicline▼, and Pandemrix®▼ influenza vaccine. Action Healthcare professionals who are considering prescribing dronedarone, pioglitazone, […]
NPC Archive Item: Varenicline▼ associated with a possible increased risk of CV events
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 18 July 2011 A meta-analysis of 14 randomised controlled trials found that varenicline▼ was associated with a small, significantly increased risk of serious adverse cardiovascular (CV) events, compared with […]
NPC Archive Item: May Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 17 May 2011 The MHRA and CHM have published the May edition of Drug Safety Update This issue gives […]
NPC Archive Item: Drug Safety Update from MHRA/CHM (February 2010)
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 19 February 2010 The MHRA and CHM have published the February edition of Drug Safety Update This edition includes […]
NPC Archive Item: October Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 15 October 2009 The MHRA and CHM have published the October edition of Drug Safety Update. There is a […]